| « News Home
September 2005 »
Pharmaceutical
Company Revenues worth $60 Billion under Threat from Generic Drugs
28 September, 2005
Brand-Name
Drug Prices Outpacing Generics
27 September, 2005
US
Experts Provides Guidelines for Erectile Dysfunction Drug Usage
27 September, 2005
Generic
Drug Sales to Soar Previous Estimates
20 September, 2005
Erectile
Dysfunction Drug Companies to Benefit from Largely Untapped Markets
in Europe
20 September, 2005
Philadelphia
based generic drug maker loses $32.8million
13 September, 2005
Novartis
unit sues FDA over a Generic Drug for Human Growth Hormone
13 September, 2005
Ranbaxy
guns for Pfizer's $12-b cholesterol drug Lipitor
12 September, 2005
India's
Generic Drug Producing Company gets a Setback
08 September, 2005
Interactive
Program Boosts Life of Prostate Cancer Patients Suffering from Erectile
Dysfunction
07 September, 2005
Generic
version of allergy aid Allegra to be sold by Barr, Teva
07 September, 2005
|
